In breast cancer, Cten is positively regulated by c-Erb-B2 protein [6] – this is over-expressed in a specific subset of breast cancers due to gene amplification and is a part of the Epidermal Growth Factor Receptor (EGFR) signalling pathway. This evidence concerns the gene EGFR and breast carcinoma.